Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203. (Q33990928)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203. |
scientific article |
Statements
1 reference
Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203. (English)
1 reference
Weijing Sun
1 reference
Mark Powell
1 reference
Peter J O'Dwyer
1 reference
Paul Catalano
1 reference
Rafat H Ansari
1 reference
Al B Benson
1 reference
10 May 2010
1 reference
1 reference
28
1 reference
18
1 reference
2947-2951
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference